DMF for Latanoprost API was filed with Slovenia and Croatia Regulatory Authorities.
DMF for Latanoprost API was filed with German and French Regulatory Authorities.
DMF for Nabilone API was filed with Health Canada.
The Company celebrated the 20th anniversary since its establishment.
GMP certificate was renewed following a successful 4 day inspection of the Company’s facility and operations by the Israeli Ministry of Health.
As part of a corporate restructuring, the Company was separated from RxElite and Dr. Arie L. Gutman became Chairman of the Board.